FMP
MaxCyte, Inc.
MXCT
NASDAQ
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.
3.69 USD
-0.05 (-1.36%)
About
ceo
Mr. Maher Masoud
sector
Healthcare
industry
Medical - Devices
website
https://maxcyte.com
exchange
NASDAQ
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electropora...
CIK
0001287098
ISIN
US57777K1060
CUSIP
57777K106
Address
9713 Key West Avenue
Phone
301 944 1700
Country
US
Employee
143
IPO Date
Jul 30, 2021
Summary
CIK
0001287098
Exchange
NASDAQ
Industry
Medical - Devices
Sector
Healthcare
CUSIP
57777K106
ISIN
US57777K1060
Country
US
Price
3.69
Beta
1.04
Volume Avg.
565.48k
Market Cap
384.24M
Shares
-
52-Week
2.45-5.545
DCF
-0.01
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-9.97
P/B
-
Website
https://maxcyte.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest MXCT News
It looks like there's no news available.
